CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA
Clinical trials for CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA trials appear
Sign up with your email to follow new studies for CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to keep chemo on track for GI cancer patients
Disease control OngoingThis study tests whether avatrombopag, a pill that boosts platelet production, can help people with gastrointestinal cancer who develop low platelets from chemotherapy. About 60 participants will receive either avatrombopag or a placebo. The goal is to see if the drug can raise p…
Matched conditions: CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA
Phase: PHASE2 • Sponsor: Hanny Al-Samkari, MD • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug may keep chemo on track for lung, ovarian, and breast cancer patients
Symptom relief OngoingThis study tests whether romiplostim can prevent chemotherapy delays or dose reductions caused by low platelet counts in people with lung, ovarian, or breast cancer. About 145 adults will receive either romiplostim or a placebo alongside their chemotherapy. The goal is to help pa…
Matched conditions: CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA
Phase: PHASE3 • Sponsor: Amgen • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC